Eric Novik, Ph.D.,
Chief Technology Officer
Dr. Novik manages HµREL’s R&D and production functions and he also serves as the Company’s principal technical liaison to scientists in HµREL’s client organizations. He has played a seminal role in the development and characterization of the HµRELhumanTM, HµRELdogTM, and HµRELratTM hepatic co-cultures, of which he is an inventor; and also of the HµRELflowTM multi-tissue microfluidic platform. Dr. Novik holds a Ph.D. in biomedical engineering from Rutgers University, where he wrote his doctoral dissertation on the differentiation of human hepatocytes from induced pluripotent stem cells.